- Home
- DYAI vs IINN Comparison
DYAI vs IINN Comparison
Compare DYAI & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYAI
- IINN
- Stock Information
- Founded
- DYAI 1979
- IINN 2018
- Country
- DYAI United States
- IINN Israel
- Employees
- DYAI N/A
- IINN N/A
- Industry
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- IINN Medical/Dental Instruments
- Sector
- DYAI Health Care
- IINN Health Care
- Exchange
- DYAI Nasdaq
- IINN Nasdaq
- Market Cap
- DYAI 30.2M
- IINN 32.4M
- IPO Year
- DYAI 2004
- IINN 2021
- Fundamental
- Price
- DYAI $0.92
- IINN $0.94
- Analyst Decision
- DYAI Strong Buy
- IINN Strong Buy
- Analyst Count
- DYAI 1
- IINN 1
- Target Price
- DYAI $3.00
- IINN $2.00
- AVG Volume (30 Days)
- DYAI 100.8K
- IINN 251.5K
- Earning Date
- DYAI 11-12-2025
- IINN 10-01-2025
- Dividend Yield
- DYAI N/A
- IINN N/A
- EPS Growth
- DYAI N/A
- IINN N/A
- EPS
- DYAI N/A
- IINN N/A
- Revenue
- DYAI $3,342,195.00
- IINN $289,000.00
- Revenue This Year
- DYAI $18.18
- IINN N/A
- Revenue Next Year
- DYAI $87.65
- IINN $2,582.74
- P/E Ratio
- DYAI N/A
- IINN N/A
- Revenue Growth
- DYAI N/A
- IINN N/A
- 52 Week Low
- DYAI $0.71
- IINN $0.40
- 52 Week High
- DYAI $2.20
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- DYAI 36.54
- IINN 39.98
- Support Level
- DYAI $0.88
- IINN $0.90
- Resistance Level
- DYAI $0.98
- IINN $1.12
- Average True Range (ATR)
- DYAI 0.08
- IINN 0.07
- MACD
- DYAI -0.02
- IINN 0.00
- Stochastic Oscillator
- DYAI 11.93
- IINN 29.62
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.